Stryker to Acquire Amplitude Vascular Systems for IVL Tech

Stryker has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform for calcified peripheral arterial disease.

AVS’ IVL technology uses pulsed CO2-generated pressure waves delivered through an IVL balloon catheter to fracture calcium and improve luminal gain. The platform is designed to enhance catheter deliverability, treatment speed, and therapy efficiency. Stryker said the acquisition will strengthen its Peripheral Vascular portfolio by adding revascularization technology once cleared for use in applicable markets. The transaction is subject to customary closing conditions, and both companies will operate separately until closing.